USPTO Examiner PELLEGRINO BRIAN E - Art Unit 3799

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19023216COBALT-CHROMIUM ALLOY STENT AND DRUG ELUTING STENTJanuary 2025June 2025Allow510NoNo
18804861Degradable biomedical magnesium alloy drug-eluting vascular stent and preparation methodAugust 2024May 2025Allow911NoNo
18587878METHOD OF PERFORMING A MINIMALLY INVASIVE BYPASSFebruary 2024November 2024Allow910YesNo
18577719LONG-ACTING ANTIBACTERIAL ANTI-STENOSIS FUNCTIONAL URETHRAL STENT AND PREPARATION METHOD THEREOFJanuary 2024March 2025Allow1411YesNo
18013510Covered StentMay 2023April 2024Allow1620YesNo
18177619METHOD FOR MAINTAINING PATENCY OF A PROSTATIC URETHRA LUMENMarch 2023June 2025Abandon2820NoYes
18109937SYSTEMS AND METHODS FOR IMPLANTING A PROSTHETIC VALVE WITHIN A NATIVE HEART VALVEFebruary 2023November 2024Allow2110NoNo
18156761Epicardial Anchor Devices And MethodsJanuary 2023February 2025Allow2510NoNo
18151196VENOUS VALVE PROSTHESISJanuary 2023April 2025Abandon2710NoNo
17901456Talar Implant System and MethodSeptember 2022December 2024Allow2810YesNo
17854795SCAFFOLDS WITH VIABLE TISSUEJune 2022April 2025Abandon3311NoNo
17778304Covered StentMay 2022November 2023Allow1820NoNo
17774977Stent GraftMay 2022August 2024Allow2740YesNo
17773576TIPS Stent Graft and KitApril 2022January 2025Allow3240NoYes
17703562STENT-GRAFT PROSTHESIS WITH PRESSURE RELIEF CHANNELSMarch 2022March 2025Allow3620NoNo
17590240NON-INVASIVELY AND SAFELY AND QUICKLY SURGICAL TECHNIQUE OF INSERTING T-SHAPED TUBE INTO STENOTIC TRACHEAFebruary 2022June 2025Allow4110NoNo
17418665Covered Stent and Preparation Method ThereforJanuary 2022February 2024Allow3140YesNo
17530187ARTICULATED COMMISSURE VALVE STENTS AND METHODSNovember 2021December 2024Allow3720NoNo
17454043TWO-PART MITRAL VALVE AND IMPLANT METHODNovember 2021July 2024Allow3210NoNo
17497199MULTI-LUMEN STENT-GRAFT AND RELATED SURGICAL METHODSOctober 2021March 2022Allow611NoNo
17494770TWO-PART BI-LEAFLET HEART VALVE PROSTHESESOctober 2021June 2025Allow4410NoNo
17460429SMALL DIAMETER VASCULAR PROSTHESISAugust 2021January 2023Allow1730YesNo
17399811METHOD OF USING AN ENDOVASCULAR STENT-GRAFT WITH AN EXTRAVASCULAR EXTENSIONAugust 2021August 2022Allow1211NoNo
17395647INTRAOPERATIVE USES OF SETTABLE SURGICAL COMPOSITIONSAugust 2021March 2024Allow3111NoNo
17372940STENT AND METHOD OF MAKING SAMEJuly 2021October 2024Allow3920NoNo
17305559DEVICE AND METHOD FOR MODIFYING THE SHAPE OF A BODY ORGANJuly 2021May 2022Allow1020YesNo
17358567DEVICE, SYSTEM, AND METHOD FOR TRANSCATHETER TREATMENT OF VALVULAR REGURGITATIONJune 2021April 2023Allow2231YesNo
17354708FLEXIBLE HOLLOW LUMEN COMPOSITEJune 2021April 2025Abandon4610NoNo
17327801Optimized Stent Jacket with Large AperturesMay 2021July 2024Abandon3810NoNo
17241808WOVEN GRAFT HAVING A TAPER WITH A RE-ENGAGED WARP ENDApril 2021January 2024Allow3221YesNo
17234999Biological Chord Repair System and MethodsApril 2021April 2024Allow3620NoNo
17214869Nasal Implants and Systems and Method of UseMarch 2021September 2024Allow4220YesNo
17214286MEDICAL DEVICE SUITABLE FOR LOCATION IN A BODY LUMENMarch 2021April 2024Abandon3710NoNo
17181783INTRAVASCULAR IMPLANTS AND METHODS OF USING THE SAMEFebruary 2021April 2024Abandon3801NoNo
17178802PROSTHETIC VALVE WITH IMPROVED WASHOUTFebruary 2021January 2024Allow3521NoNo
17174839METHODS AND USES OF BIOLOGICAL TISSUES FOR VARIOUS STENT AND OTHER MEDICAL APPLICATIONSFebruary 2021November 2024Abandon4520NoNo
17146760SYSTEM AND METHOD FOR MEASURING BLOOD FLOW PARAMETERS IN A BLOOD VESSEL HAVING AN ENDOVASCULAR PROSTHESISJanuary 2021February 2024Abandon3710NoNo
17142887VASCULAR VALVE PROSTHESISJanuary 2021December 2023Abandon3510NoNo
17134542Stent assembly and methods for treatment via body lumensDecember 2020May 2024Abandon4120NoNo
17134318METHOD FOR HUMAN IMMORTALITYDecember 2020December 2024Abandon4810NoNo
17100345BIFURCATED SIDE-ACCESS INTRAVASCULAR STENT GRAFTNovember 2020January 2022Abandon1420YesNo
17061347TRANSCATHETER DEVICE, SYSTEM AND METHOD FOR TREATING TYPE A AORTIC DISSECTIONOctober 2020December 2023Allow3810YesNo
17015677IMPLANTABLE PROSTHETIC HEART VALVESeptember 2020April 2021Allow710YesNo
17005746IMPLANTABLE VASCULAR DEVICE HAVING LONGITUDINAL STRUTSAugust 2020March 2025Abandon5530NoNo
16970460BRAIDED STRUCTURE, IN PARTICULAR STENT, AND METHOD FOR BRAIDING A BRAIDED STRUCTUREAugust 2020July 2024Abandon4741YesNo
16957941ABSORBABLE METAL STENTJune 2020July 2023Allow3631NoNo
16955942SOFT TISSUE IMPLANT POCKETJune 2020February 2025Allow5660YesNo
16888322VALVE TRANSLOCATION DEVICE AND METHOD FOR THE TREATMENT OF FUNCTIONAL VALVE REGURGITATIONMay 2020November 2020Allow620YesNo
16879346DUAL VOLTAGE SOLAR PANELMay 2020August 2024Allow5120NoNo
16857914Heart Valve AssembliesApril 2020September 2023Abandon4110NoNo
16843422STENT AND MEDICAL DEVICE COMPRISING SAMEApril 2020March 2025Abandon6040YesNo
16840403MODULAR VALVE PROSTHESIS WITH ANCHOR STENT AND VALVE COMPONENTApril 2020December 2022Allow3200NoNo
16838625AIRWAY STENTSApril 2020March 2023Allow3521YesNo
16649087TEXTILE INSERT FOR MEDICAL PURPOSES, AND METHOD FOR PRODUCING SAMEMarch 2020August 2023Abandon4110NoNo
16648801IMPLANTABLE DEVICEMarch 2020May 2025Allow6050YesNo
16642730METAL ALLOY AND MEDICAL DEVICE CONTAINING SAMEFebruary 2020April 2024Allow4931YesNo
16790875Epicardial Anchor Devices And MethodsFebruary 2020November 2022Allow3320YesNo
16743049STENT INCLUDING ANTI-MIGRATION CAPABILITIESJanuary 2020February 2024Allow4941YesNo
16630603Intravascular Stent, Especially for Coronary VesselsJanuary 2020July 2023Abandon4220NoNo
16734881Replacement Mitral ValvesJanuary 2020November 2022Allow3420YesNo
16729382Mechanical Parts Including Pyrolytic Carbon Brace MembersDecember 2019September 2022Abandon3210NoNo
16714712GEOMETRICALLY TUNABLE HYDROGEL-BASED CHEMICALLY-ELUTING SHUNT PROSTHESISDecember 2019September 2024Abandon5831NoNo
16695008ASSEMBLY OF HEART VALVES AND INTERMEDIATE ADAPTER STENTNovember 2019May 2023Allow4220YesNo
16612540INTRAVASCULAR RETRIEVABLE CELL DELIVERY SYSTEMNovember 2019August 2024Allow5730YesNo
16673200VALVE DELIVERY SYSTEMNovember 2019March 2023Abandon4011NoNo
16609764IMPLANTABLE VASCULAR GRAFTSOctober 2019April 2025Abandon6041NoNo
16597460PERCUTANEOUS MITRAL VALVE REPLACEMENT DEVICEOctober 2019August 2023Allow4631YesNo
16583880Spinal ImplantSeptember 2019April 2022Abandon3010NoNo
16567755ADJUSTABLE ORTHOPEDIC CONNECTIONSSeptember 2019August 2023Allow4741YesNo
16526843DEVICE AND METHOD FOR MODIFYING THE SHAPE OF A BODY ORGANJuly 2019February 2022Allow3110YesNo
16518139IMPLANTABLE DEVICES AND TECHNIQUES FOR ONCOPLASTIC SURGERYJuly 2019August 2022Allow3721YesNo
16510104Talar Implant System and MethodJuly 2019May 2022Allow3420NoNo
16508977INTERSPINOUS IMPLANTJuly 2019September 2021Abandon2621NoNo
16502696DRUG DELIVERY SYSTEM AND METHOD OF MANUFACTURING THEREOFJuly 2019February 2023Abandon4440NoNo
16459177Nasal Implants and Systems and Method of UseJuly 2019December 2020Allow1811YesNo
16431128STENT WITH SELECTIVELY CURVED REGIONJune 2019September 2022Allow4020YesYes
16389312MECHANICALLY EXPANDABLE HEART VALVE WITH LEAFLET CLAMPSApril 2019January 2022Allow3310YesNo
16388185Methods For Surgical Valve ExpansionApril 2019September 2021Allow2910YesNo
16388138COATED STENT WITH SURFACE STRUCTURE OR PLACEHOLDER MATERIAL TO REDUCE CRACK FORMATIONApril 2019December 2021Abandon3210NoNo
16383366EXPANDABLE AORTIC OR PULMONARY ROOTApril 2019December 2021Allow3220YesNo
16340645BLOOD CONDUIT WITH STENTApril 2019November 2022Allow4330NoNo
16340081TUBULAR WOVEN FABRICApril 2019April 2022Allow3720YesNo
16374962CUSTOM DENTAL MEMBRANEApril 2019May 2021Allow2610YesNo
16334330FLEXIBLE STENTMarch 2019November 2021Allow3250NoNo
16287519STENT AND METHOD OF MAKING SAMEFebruary 2019March 2021Allow2521YesNo
16276158VENOUS VALVE PROSTHESISFebruary 2019October 2022Allow4431YesNo
16316403SYSTEM AND METHOD FOR MEASURING BLOOD FLOW PARAMETERS IN A BLOOD VESSEL HAVING AN ENDOVASCULAR PROSTHESISJanuary 2019December 2020Allow2410YesNo
16228274BIDIRECTIONAL STENT AND METHOD OF USE THEREOFDecember 2018June 2021Abandon2920NoNo
16219800Single Layer ePTFE And Discrete Bio-Resorbable RingsDecember 2018May 2021Allow2920YesYes
16218157Prosthetic Attachment Device for Osseointegrated ImplantsDecember 2018September 2021Allow3311NoNo
16218007INDWELLING BODY LUMEN EXPANDERDecember 2018June 2023Abandon5460NoNo
16309063TWO-PART MITRAL VALVE AND IMPLANT METHODDecember 2018August 2021Allow3321YesNo
16204355HEART VALVE SEALING DEVICES AND DELIVERY DEVICES THEREFORNovember 2018August 2021Allow3221NoNo
16196221ARTICULATED COMMISSURE VALVE STENTS AND METHODSNovember 2018July 2021Allow3221NoNo
16183221INTRAOPERATIVE USES OF SETTABLE SURGICAL COMPOSITIONSNovember 2018May 2021Allow3011YesNo
16178626BIDIRECTIONAL STENT AND METHOD OF USE THEREOFNovember 2018May 2022Abandon4240NoNo
16165299TISSUE PRODUCTS WITH VARIATIONS IN MECHANICAL PROPERTIES AND METHODS OF TREATMENTOctober 2018May 2024Abandon6070NoNo
16135466SYSTEMS AND METHODS FOR IMPLANTING A PROSTHETIC VALVE WITHIN A NATIVE HEART VALVESeptember 2018November 2020Allow2630NoYes
16135505PROSTHETIC VALVE WITH INNER AND OUTER FRAMES CONNECTED AT A LOCATION OF TISSUE ANCHOR PORTIONSeptember 2018March 2021Allow3030YesNo
16086508TRANSAPICALLY-IMPLANTED MITRAL VALVE FLEXIBLE COAPTATION PLATE BLOCKING BODY AND IMPLANTATION METHODSeptember 2018January 2021Allow2820YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner PELLEGRINO, BRIAN E.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
17
Examiner Affirmed
14
(82.4%)
Examiner Reversed
3
(17.6%)
Reversal Percentile
28.5%
Lower than average

What This Means

With a 17.6% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
45
Allowed After Appeal Filing
10
(22.2%)
Not Allowed After Appeal Filing
35
(77.8%)
Filing Benefit Percentile
26.8%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 22.2% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner PELLEGRINO, BRIAN E - Prosecution Strategy Guide

Executive Summary

Examiner PELLEGRINO, BRIAN E works in Art Unit 3799 and has examined 202 patent applications in our dataset. With an allowance rate of 73.3%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 37 months.

Allowance Patterns

Examiner PELLEGRINO, BRIAN E's allowance rate of 73.3% places them in the 29% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by PELLEGRINO, BRIAN E receive 2.89 office actions before reaching final disposition. This places the examiner in the 94% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by PELLEGRINO, BRIAN E is 37 months. This places the examiner in the 16% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +25.9% benefit to allowance rate for applications examined by PELLEGRINO, BRIAN E. This interview benefit is in the 76% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 13.2% of applications are subsequently allowed. This success rate is in the 4% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 42.9% of cases where such amendments are filed. This entry rate is in the 59% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 90.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 66% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 56.4% of appeals filed. This is in the 23% percentile among all examiners. Of these withdrawals, 54.5% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.

Petition Practice

When applicants file petitions regarding this examiner's actions, 51.9% are granted (fully or in part). This grant rate is in the 64% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 4.0% of allowed cases (in the 86% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 2.7% of allowed cases (in the 70% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.
  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.